Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang)

Therapeutic Drug Monitoring

Volumn 20, Issue 4, 1998, Pages 439-445

  Gurley, Bill J ^a   Gardner, Stephanie F ^a   White, Laura M ^a   Wang, Pei Ling ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Ephedra sinica; Ephedrine; Ma huang; Pharmacokinetics

Indexed keywords

EPHEDRA SINICA EXTRACT; EPHEDRINE; ESCALATION; EXCEL; HERBACEOUS AGENT; UNCLASSIFIED DRUG; UP YOUR GAS;

ADULT; ANOREXIA; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG MONITORING; DRUG OVERDOSE; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TRADITIONAL MEDICINE;

ADULT; ALKALOIDS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; EPHEDRINE; FEMALE; HUMANS; MALE; PLANTS, MEDICINAL; SEX FACTORS; SYMPATHOMIMETICS;

EID: 0031823286     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199808000-00015     Document Type: Article

References (29)

1. Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995;273:607-9.
2. Tyler VE. What pharmacists should know about herbal remedies. J Am Pharm Assoc 1996;NS36:29-37.
3. Tyler VE. The Honest Herbal. 3rd ed. New York: Pharmaceutical Products Press; 1993:119-21.
4. Josefson D. Herbal stimulant causes US deaths. Br Med J 1996; 312:1378-9.
5. Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis [letter]. Br Med J 1996;313:756.
6. Ault A. FDA proposes limits on ephedrine supplements [letter]. Lancet 1997;349:1753.
7. Nightingale SL. Warning issued about the street drugs containing botanical sources of ephedrine [letter]. JAMA 1996;275:1534.
8. US Department of Health and Human Services. FDA Statement on Street Drugs Containing Botanical Ephedrine. Washington, DC: Food and Drug Administration; April 10, 1996.
9. White LM, Gardner SF, Gurley BJ, Marx MA, Wang P, Estes M. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol 1997;37: 116-22.
10. Shenfield GM. Combination bronchodilator therapy. Drugs 1982; 24:414-39.
11. Pentel P. Toxicity of over-the-counter stimulants. JAMA 1984;252: 1898-903.
12. Upton RA. Pharmacokinetic interactions between theophylline and other medication. Clin Pharmacokinet 1991;20:66-80.
13. Kanfer I, Dowse R, Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993;13:116S-128S.
14. Brendel E, Meineke I, Henne E, Zschunke M, De Mey C. Sensitive high-performance liquid chromatographic determination of pseudoephedrine in plasma and urine. J Chromatogr 1988;426:406-11.
15. Sagara K, Oshima T, Misake T. A simultaneous determination of norephedrine, pseudoephedrine, ephedrine, and methylephedrine in ephedra herb and oriental pharmaceutical preparations by ion-pair high performance liquid chromatography. Chem Pharm Bull (Tokyo) 1983;31:2359-65.
16. Gurley BJ, Wang P, Gardner SF. Ephedrine alkaloid content of five commercially available herbal products containing Ephedra sinica (ma-huang). Pharm Res 1997;14:5582-3.
17. Nieder M, Jaeger H. Sensitive quantification of pseudoephedrine in human plasma and urine by high-performance liquid chromatography. J Chromatogr 1988;424:73-82.
18. Lu D, Mao F. An interactive program for pharmacokinetic modeling. J Pharm Sci 1993;82:537-42.
19. Wagner J. Linear pharmacokinetic equations allowing for direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 1976;4: 443-67.
20. Wilkinson GR, Beckett AH. Absorption, metabolism and excretion of the ephedrines in man, II: pharmacokinetics. J Pharm Sci 1968; 57:1933-8.
21. Welling PG, Lee KP, Patel JA, Walker JE, Wagner JG. Urinary excretion of ephedrine in man without pH control following oral administration of three commercial ephedrine sulfate preparations. J Pharm Sci 1971;60:1629-34.
22. Pickup ME, May CS, Senadagrie RS, Patterson JW. The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. Br J Clin Pharmacol 1976;3:123-34.
23. Stromberg C, Vanakoski J, Olkkola KT, Lindquist A, Seppala T, Laitinen LA. Exercise alters the pharmacokinetics of midazolam. Clin Pharmacol Ther 1992;51:527-32.
24. Vanakoski J, Stromberg C, Seppala T. Effects of a sauna on the pharmacokinetics of midazolam and ephedrine in healthy young women. Eur J Clin Pharmacol 1993;45:377-81.
25. Tyler VE, Brady LR, Roberts JE. Pharmacognosy. 9th ed. Philadelphia: Lea & Febiger; 1988:245-7.
26. Yoovathaworn KC. Influence of caffeine on aspirin pharmacokinetics. Eur J Drug Metab Pharmacokinet 1986;11:71-4.
27. Brown JM, Ryder D, Branch RA. A pharmacodynamic interaction between caffeine and phenylpropanolamine. Clin Pharmacol Ther 1991;50:363-71.
28. Zhang JS, Tian Z, Lou ZC. Quality evaluation of twelve species of Chinese Ephedra (ma-huang). Acta Pharm Sinica 1993;22:419-25.
29. Betz JM, Gay ML, Magdi MM, Adams S. Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing ma huang. J Am Org Anal Chem Int 1997; 80:303-15.